Computer-based Training of Face Recollection to Improve Face Recognition in Developmental Prosopagnosia
NCT ID: NCT04799340
Last Updated: 2022-11-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2021-03-12
2025-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Face Perception vs. Memory Training to Improve Face Recognition in Developmental Prosopagnosia
NCT05800782
Memory Training in Patients With Amnestic Mild Cognitive Impairment
NCT01978353
Remediation of Spatial Neglect Trial
NCT01965951
Impact of Intensive Computerized Cognitive Training
NCT06130735
Exercise Training to Improve Cognitive Function
NCT03824639
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
holistic face training + repetition lag training
cognitive training
training to improve encoding and recognition of faces
waitlist control
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cognitive training
training to improve encoding and recognition of faces
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 18-90,
* have lifelong histories of face recognition difficulties that impact their everyday life (i.e., not associated with some event such as a stroke, seizure, etc)
* score significantly below the mean on the famous faces test and Cambridge Face Memory Test
Exclusion Criteria
* have a history of a significant neurological disorder including hydrocephalus, stroke, moderate to severe traumatic brain injury (TBI), severe neuromuscular diseases, or severe hypoxia due to cardiac arrest.
* have impairments that interfere with cognitive performance, such as uncorrected hearing or vision, lack of English proficiency, musculoskeletal or other issues
* have psychiatric disorders, such as schizophrenia, major depressive disorder, bipolar disorder, chronic intractable obsessive-compulsive disorder, or agoraphobia.
* We will exclude individuals who are currently dependent on alcohol or other substances, as this may negatively impact cognitive performance.
* We will exclude participants who currently are, or within the last 6 months, participating in a behavioral or pharmacological intervention.
* Patients with a history of mild TBI or simple concussion will not be excluded as long as it was \> 6 months ago and as long as they have not had repeated concussions (\>5)
* We will include individuals with a diagnosis of ADHD as long as their medication has been consistent for the past 6 months.
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston VA Research Institute, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joseph DeGutis
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Boston Healthcare System, 150 S. Huntington Ave.
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R21EY031000, R01EY032510
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.